跳至主要内容
临床试验/NCT03845868
NCT03845868招募中不适用

Tongji-Ezhou Prospectively Cohort Study

Huazhong University of Science and Technology1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2013年4月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10,000
试验地点
1
主要终点
Diabetic complications

研究概览

简要总结

Tongji-Ezhou study (TJEZ) is a prospective cohort study launched at 2013 in EZhou city, Hubei province, with the goal of recruiting and assessing 10,000 individuals and then following them for at least 2 decades. In addition, blood samples would be collected every 3-5 years among 6000 of them to investigate the nutritional biomarkers and potential determinants of chronic diseases such as obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (i) permanent residence in Ezhou district (minimum of 9 months); (ii) written informed consent; (iii) age ≥ 20 years old at the time of enrolling in the study.

排除标准

  • (i) with chemotherapy or radiotherapy for cancer and other severe diseases.

结局指标

主要结局

Diabetic complications

时间窗: mean follow up of 10 years

Development of diabetic complications

Incidence of diabetes

时间窗: 5 years

Type 2 diabetes was diagnosed when FPG ≥ 7.0 mmol/L and/or OGTT2h ≥ 11.1 mmol/L, or using diabetic medication (self-report).

Incidence of metabolic syndrome

时间窗: 5 years

Metabolic syndrome is defined as using the updated National Cholesterol Education Program/Adult Treatment Panel III criteria for Asian Americans. These criteria require three or more of the following components: (1) central obesity (waist circumference of ≥90 cm for men or ≥80 cm for women), (2) triglycerides of ≥1.7 mmol/L, (3) HDL-C of \<1.03 mmol/L for men or \<1.30 mmol/L for women, (4) blood pressure of ≥130/85 mmHg or on medication for hypertension, and (5) fasting glucose of ≥5.6 mmol/L.

Incidence of cardiovascular diseases

时间窗: mean follow up of 10 years

Cardiovascular death, stroke, myocardial infarction, heart failure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Liegang Liu

Vice dean of School of Public Health, Tongji Medical College

Huazhong University of Science and Technology

研究点 (1)

Loading locations...

相似试验